Business
Ocular Therapeutix™ to Present Data at the American Academy of Optometry Annual Meeting 2021
BEDFORD, Mass.--(BUSINESS WIRE)-- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and
About this update from Ocular Therapeutix, Inc.
[{"type":"text","content":" BEDFORD, Mass.--(BUSINESS WIRE)--\nOcular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scientific presentations at the American Academy of Optometry (AAOPT) Annual Meeting 2021 being held in Boston, MA November 3 - 6, 2021.\n\n“The AAOPT is the largest meeting in optometry and works to maintain and enhance excellence in optometric practice, by both promoting research and the dissemination of knowledge,” said Michael Goldstein, MD, MBA, President, Ophthalmology and Chief Medical Officer of Ocular Therapeutix. “We are pleased to have a number of company-sponsored and investigator-initiated presentations at this year’s event highlighting the use of DEXTENZA® for the treatment of ocular inflammation and pain as well as for our recently approved label, for the treatment of ocular itching associated with allergic conjunctivitis.”\n\nPresentations / Posters\n\n\nTitle: Pooled Analysis of a Hydrogel-based Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis\nPresenter: Walter Whitley, OD\nDate / Time: Thursday, November 4th, 4:30 – 6:30pm ET\nLocation: Podium Presentation, Room 253 ABC\n\n\nTitle: Effects of Punctal Occlusion on Ocular Itching and Conjunctival Redness Associated with Allergic Conjunctivitis\nPresenter: Nysha Blender, OD\nDate / Time: Friday, November 5th, 10:00am – 12:00pm ET\nLocation: Poster Board #27, Exhibit Hall B1\n\n\nInvestigator-initiated Trial Presentations\n\n\nTitle: Comparison of Intracanalicular Dexamethasone Insert to Loteprednol Etabonate Ophthalmic gel 0.38% in Patients with Keratoconus, Allergies and Dry Eye\nPresenter: Jennifer Harthan, OD\nDate / Time: Thursday, November 4th, 4:30 – 6:30pm ET\nLocation: Poster Board #99, Exhibit Hall B1\n\n\nTitle: Comparison of Preoperative vs Postoperative Dexamethasone Intracanalicular Insert Placement in Controlling Pain & Inflammation following CE/PCIOL.\nPresenter: Lindsey Harris, OD\nDate / Time: Friday, November 5th, 10:00am – 12:00pm ET\nLocation: Poster Board #29, Exhibit Hall B1\n\n\nAll presentations will be available as of November 5th on the Company’s website (www.ocutx.com, under the Investors tab).\n\nAbout Ocular Therapeutix, Inc.\nOcular Therapeutix, Inc. is a...